etoposide has been researched along with 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mashima, T; Matsuura, M; Miyata, S; Okabe, S; Sato, S; Seimiya, H; Sugimoto, Y; Tsuruo, T | 1 |
1 other study(ies) available for etoposide and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium
| Article | Year |
|---|---|
Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzimidazoles; Caspases; Catalysis; Cell Line, Tumor; Cell Survival; Coenzyme A Ligases; Cytochrome c Group; Dose-Response Relationship, Drug; Etoposide; Fluorescent Antibody Technique; Fluorescent Dyes; Glioma; Humans; Indoles; Injections, Subcutaneous; Isoenzymes; Mice; Mice, Nude; Neoplasm Transplantation; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Triazenes; Tumor Burden; Xenograft Model Antitumor Assays | 2009 |